Biogen (BIIB) Income from Non-Controlling Interests (2016 - 2023)
Historic Income from Non-Controlling Interests for Biogen (BIIB) over the last 13 years, with Q4 2023 value amounting to -$800000.0.
- Biogen's Income from Non-Controlling Interests rose 1111.11% to -$800000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was -$800000.0, marking a year-over-year decrease of 36666.67%. This contributed to the annual value of $400000.0 for FY2023, which is 10046.89% up from last year.
- As of Q4 2023, Biogen's Income from Non-Controlling Interests stood at -$800000.0, which was up 1111.11% from -$200000.0 recorded in Q3 2023.
- In the past 5 years, Biogen's Income from Non-Controlling Interests ranged from a high of $577.0 million in Q2 2021 and a low of -$388.7 million during Q4 2021
- Over the past 4 years, Biogen's median Income from Non-Controlling Interests value was -$300000.0 (recorded in 2020), while the average stood at $9.2 million.
- Over the last 5 years, Biogen's Income from Non-Controlling Interests had its largest YoY gain of 79596.27% in 2021, and its largest YoY loss of 12946666.67% in 2021.
- Over the past 4 years, Biogen's Income from Non-Controlling Interests (Quarter) stood at -$300000.0 in 2020, then tumbled by 129466.67% to -$388.7 million in 2021, then skyrocketed by 99.77% to -$900000.0 in 2022, then grew by 11.11% to -$800000.0 in 2023.
- Its Income from Non-Controlling Interests was -$800000.0 in Q4 2023, compared to -$200000.0 in Q3 2023 and $1.7 million in Q2 2023.